ArticleCanadian journal of kidney health and disease2016
Comparative effectiveness of home dialysis therapies: a matched cohort study.
Article in Canadian journal of kidney health and disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Comparison of peritoneal dialysis with hemodialysis on survival of diabetic patients with end-stage kidney disease: a meta-analysis of cohort studies.Renal failure · 2019Pooled it
- A Comparison of Hospitalization Outcomes Between Peritoneal Dialysis and Home Hemodialysis Patients by Sex and Race.Kidney international reports · 2025Article
- Severe acute respiratory infections: An epidemiological analysis of surveillance data in Bahrain, 2018-2022.Qatar medical journal · 2024Article
- Cost of the quanta SC+ hemodialysis system for self-care in the United Kingdom.Hemodialysis international. International Symposium on Home Hemodialysis · 2022Review
- Improved long-term survival with home hemodialysis compared with institutional hemodialysis and peritoneal dialysis: a matched cohort study.BMC nephrology · 2019Article
- Health economic evaluation of peritoneal dialysis based on cost-effectiveness in Japan: a preliminary study.ClinicoEconomics and outcomes research : CEOR · 2019Article
- Mortality and Hospitalizations in Intensive Dialysis: A Systematic Review and Meta-Analysis.Canadian journal of kidney health and disease · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHome dialysis is being increasingly promoted among patients with end-stage renal disease, but the comparative effectiveness of home hemodialysis and peritoneal dialysis is unknown.
objectiveTo determine whether patients receiving home daily hemodialysis have reduced mortality risk compared with matched patients receiving home peritoneal dialysis.
designThis study is an observational, propensity-matched, new-user cohort study.
settingLinked electronic data were from the United States Renal Data System (USRDS) and a large dialysis provider's database. PATIENTS: The patients were adults receiving in-center hemodialysis in the USA between 2004 and 2011 and registered in the USRDS. MEASUREMENTS: Baseline comorbidities, demographics, and outcomes for both groups were ascertained from the United States Renal Data System.
methodsWe identified 3142 consecutive adult patients initiating home daily hemodialysis (≥5 days/week for ≥1.5 h/day) and matched 2688 of them by propensity score to 2688 contemporaneous US patients initiating home peritoneal dialysis. We used Cox regression to compare all-cause mortality between groups.
resultsAfter matching, the two groups were well balanced on all baseline characteristics. Mean age was 51 years, 66 % were male, 72 % were white, and 29 % had diabetes. During 10,221 patient-years of follow-up, 1493/5336 patients died. There were significantly fewer deaths among patients receiving home daily hemodialysis than those receiving peritoneal dialysis (12.7 vs 16.7 deaths per 100 patient-years, respectively; hazard ratio (HR) 0.75; 95 % CI 0.68-0.82; p < 0.001). Similar results were noted with several different analytic methods and for all pre-specified subgroups. LIMITATIONS: We cannot exclude residual confounding in this observational study.
conclusionsHome daily hemodialysis was associated with lower mortality risk than home peritoneal dialysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.